| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Peptide Pharmacology and Functional Morphology Sections, Womens Health Research Institute, Wyeth-Ayerst Research, Radnor, Pennsylvania 19087
Address all correspondence and requests for reprints to: Francisco J. Lopez, Ligand Pharmaceuticals, Inc., Endocrinology and CNS Pharmacology, 10275 Science Center Drive, San Diego, California 92121.
Estradiol imprinting plays an important role in the regulation of
galanin (GAL) gene expression in the rat. In the anterior pituitary
gland, GAL gene expression is greatly induced by estrogen. The relative
involvement that the two estrogen receptor subtypes,
and ß, have
in regulating this induction is not known. We have utilized
ER
-knock-out (ER
KO) mice to discriminate the roles of ER
and
ERß in the regulation of GAL gene expression in the anterior
pituitary gland. Our goals were to measure the effects of estradiol on
GAL gene expression by solution hybridization ribonuclease protection
assay in wild-type mice and to determine the roles of ER
and,
indirectly, ERß by measuring the same response in the ER
KO mice.
Estradiol treatment for one week elevated GAL gene expression 3040
fold in the wild-type mouse pituitary. Evaluation of estrogen effects
on GAL gene expression in the anterior pituitary of ER
KO animals
revealed that ER
is essential, because no response to estrogen was
observed in these animals. Since ERß mRNA was identified in the
anterior pituitary by RT-PCR, but estrogen had no effects on GAL gene
expression in the ER
KO mice, the ß subtype of ER does not appear
to participate in estrogen-evoked GAL gene expression in the mouse
anterior pituitary.
This article has been cited by other articles:
![]() |
J. Y.-L. Yu, C.-H. Pon, H.-C. Ku, C.-T. Wang, and Y.-H. Kao A preprogalanin cDNA from the turtle pituitary and regulation of its gene expression Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1649 - R1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
Genetically Modified Animals in Endocrinology Endocr. Rev., August 1, 2004; 25(4): 673 - 677. [Full Text] [PDF] |
||||
![]() |
S. T. Hentges and M. J. Low Ovarian Dependence for Pituitary Tumorigenesis in D2 Dopamine Receptor-Deficient Mice Endocrinology, December 1, 2002; 143(12): 4536 - 4543. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sakamoto, T. Ubuka, C. Kohchi, D. Li, K. Ukena, and K. Tsutsui Existence of Galanin in Lumbosacral Sympathetic Ganglionic Neurons That Project to the Quail Uterine Oviduct Endocrinology, December 1, 2000; 141(12): 4402 - 4412. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cai, J. D. Hayes, N. Patel, and J. F. Hyde Targeted Overexpression of Galanin in Lactotrophs of Transgenic Mice Induces Hyperprolactinemia and Pituitary Hyperplasia Endocrinology, November 1, 1999; 140(11): 4955 - 4964. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |